SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Lupin

Lupin

BSE: 500257|NSE: LUPIN|ISIN: INE326A01037|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jan 23, 10:11
1459.25
-5.75 (-0.39%)
VOLUME 5,147
LIVE
NSE
Jan 23, 09:51
1466.60
1.25 (0.09%)
VOLUME 117,428
News on Lupin
Select Year: 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Buy Jayshree Tea, Kohinoor Foods; sell HDIL, Lupin: Thakkar 

9.37 am | 23 Jan 2017 |  Source: CNBC-TV18

Mitessh Thakkar of miteshthacker.com recommends buying Jayshree Tea and Kohinoor Foods and advises selling HDIL and Lupin....

Support for Nifty at 8319; Axis Bank bearish play: Prakash Gaba

8.05 am | 23 Jan 2017 |  Source: Moneycontrol.com

According to Prakash Gaba of prakashgaba.com, Nifty has support at 831 and resistance at 8435 while Bank Nifty has support at 18639 and resistance at ...

Coal India may test Rs 300, Lupin Rs 1440: Prakash Gaba 

3.21 pm | 20 Jan 2017 |  Source: CNBC-TV18

According to Prakash Gaba of prakashgaba.com, Coal India may test Rs 300 while Lupin may hit Rs 1440....

Lupin Q3 PAT may dip 6.8% to Rs 620 cr: HDFC Securities

2.55 pm | 17 Jan 2017 |  Source: Moneycontrol.com

Net Sales are expected to increase by 1.8 percent Q-o-Q (up 22.9 percent Y-o-Y) to Rs 4370 crore, according to HDFC Securities....

Lupin Q3 PAT may dip 5% to Rs 629.1 cr: ICICI Securities

12.36 pm | 16 Jan 2017 |  Source: Moneycontrol.com

Net Sales are expected to decrease by 3.4 percent Q-o-Q (up 16.6 percent Y-o-Y) to Rs 4144.7 crore, according to ICICI Securities....

Q3 results: Five trends to watch out from Indian drugmakers

2.00 pm | 14 Jan 2017 |  Source: Moneycontrol.com

Analysts predict Q3 to be a tough quarter with revenue growth moderating to 11.7 percent in October-December period compared to 18.4 percent compounde...

Lupin launches generic morphine sulfate tablets in US

12.44 pm | 13 Jan 2017 |  Source: PTI

The company said it has launched the morphine sulfate ER Tablets in strengths of 15 mg, 30 mg, 60 mg, 100 mg and 200 mg having received an approval fr...

Lupin up 2%, launches generic MS Contin ER tablets in US

12.30 pm | 13 Jan 2017 |  Source: Moneycontrol.com

The company has launches Morphine Sulfate ER tablets 15 mg, 30 mg, 60 mg, 100 mg and 200 mg having received an approval from United State Food and Dru...

Lupin launches generic MS Contin ER tablets in US

11.42 am | 13 Jan 2017 |  Source: Moneycontrol.com

Lupin has launches its Morphine Sulfate ER tablets 15 mg, 30 mg, 60 mg, 100 mg and 200 mg having recived an approval from USFDA earlier to market gene...

Lupin Q3 PAT may dip 9.5% to Rs 599.5 cr: KR Choksey

11.40 am | 13 Jan 2017 |  Source: Moneycontrol.com

Net Sales are expected to decrease by 3.6 percent Q-o-Q (up 20.9 percent Y-o-Y) to Rs 4060.2 crore, according to KR Choksey....

Buy, sell, hold: 12 stocks to watch out as earnings start

9.00 am | 13 Jan 2017 |  Source: Moneycontrol.com

JP Morgan stays neutral on TCS with target of Rs 2450 per share as company has shown weakness in revenue growth trajectory in recent quarters. ...

Top buzzing stocks to trade on January 12 

12.29 pm | 12 Jan 2017 |  Source: CNBC-TV18

Here are a few top buzzing stocks picked by CNBC-TV18's analysts in trade today -- Idea Cellular, Sun Pharma, DRL, Lupin, Aurobindo Pharma , Glenmark,...

Buy BoI, Dalmia Bharat, IDFC, Page Industries: Mitesh Thacker 

9.40 am | 12 Jan 2017 |  Source: CNBC-TV18

Mitesh Thacker of miteshthacker.com is of the view that one can buy Bank of India, Dalmia Bharat, IDFC and Page Industries and has a conditional buy o...

Lupin gets USFDA nod to market its skin cream

2.40 pm | 11 Jan 2017 |  Source: PTI

Lupin said in a BSE filing that it "has received final approval for its Desoximetasone cream USP, 0.05 percent and Desoximetasone cream USP, 0.25 perc...

Lupin receives FDA approval for Generic Topicort LP Emollient cream and Topicort cream

2.12 pm | 11 Jan 2017 |  Source: Moneycontrol.com

Lupin has received final approval for its Desoximetasone cream USP, 0.05 percent and Desoximetasone cream USP, 0.25 percent from the USFDA to market a...

Indian drug market growth moderates to 7.2% in December

8.18 pm | 09 Jan 2017 |  Source: Moneycontrol.com

The domestic drug market grew at 7.2 percent in December, compared to 15.5 percent growth in November due to slowdown in uptake of chronic portfolio a...

Six in Sixty: Stocks you should keep on your radar 

3.20 pm | 09 Jan 2017 |  Source: CNBC-TV18

CNBC-TV18's Mangalam Maloo lists stocks that you should focus on -Tech Mahindra, HCL Technologies, TCS, Dr Reddys, Lupin, Sun Pharmaceutical, Tata Mot...

Base effect in metals, PSBs may aid Q3 earnings: Edelweiss 

10.00 am | 09 Jan 2017 |  Source: CNBC-TV18

Valuation in the information technology sector is favourable but challenges in terms of earnings and uncertainty on Trump’s policies make them good ...

Buy, sell, hold: 11 stocks that analysts are watching out today

8.40 am | 09 Jan 2017 |  Source: Moneycontrol.com

Nomura has a buy ratings on Dr Reddy’s, Glenmark, Alkem, Cadila and Jubilant Life. It says Teva’s 2017 guidanceis lower than what was presented i...

Charts 2017: Mitesh Thacker's top picks & outlook on Nifty 

10.43 am | 05 Jan 2017 |  Source: CNBC-TV18

In this special series of Charts 2017, Mitesh Thacker of miteshthacker.com shared a few of his top picks, sectoral charts for the year and his outlook...

1 2 3 4 5 6 7 8 9
Quick Links for Lupin
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.